LOS ANGELES, Jan. 10, 2025 /PRNewswire/ -- Today, XPPen has officially launched a remarkable addition to its professional ...

Noting BTC's retreat from the $100k mark a week into the new year, the analysis showed on-risk assets including crypto bore ...

AAC's acoustic solutions extend across a variety of smart devices, including smartphones, foldable phones, XR headsets, and ...

CHARLOTTE, N.C., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Coca‑Cola Consolidated, Inc. (NASDAQ: COKE) announced today that Executive Vice President and Chief Financial Officer (CFO), Scott Anthony, will ...

In December 2024, NextCure announced that the U.S. Food and Drug Administration had cleared its Investigational New Drug application for LNCB74. LNCB74 is being developed in partnership with LigaChem ...

About the Phase 1 First-in-human Study of LAVA-1266 (ACTRN12624001214527) ...

SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's growth, ...

Recently, Trina Storage has once again secured a top spot in BloombergNEF's (BNEF) Energy Storage System Cost Survey 2024, ...

High Roller Technologies, Inc. (“High Roller” and the “Company”) (NYSE American: ROLR), operator of and each a premium brand in online gaming and a destination for high rollers, is pleased to ...

Ultima Markets celebrated a landmark evening for the financial trading industry as the Traders Fair concluded in grand style.

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...